KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Asset Writedowns and Impairment (2018 - 2019)

Historic Asset Writedowns and Impairment for Opko Health (OPK) over the last 6 years, with Q4 2019 value amounting to $91.7 million.

  • Opko Health's Asset Writedowns and Impairment rose 32127.38% to $91.7 million in Q4 2019 from the same period last year, while for Sep 2020 it was $91.7 million, marking a year-over-year increase of 30897.34%. This contributed to the annual value of $92.4 million for FY2019, which is 32428.14% up from last year.
  • Per Opko Health's latest filing, its Asset Writedowns and Impairment stood at $91.7 million for Q4 2019, which was up 32127.38% from $655000.0 recorded in Q1 2019.
  • In the past 5 years, Opko Health's Asset Writedowns and Impairment ranged from a high of $91.7 million in Q4 2019 and a low of -$8.3 million during Q4 2015
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $655000.0 (2019), whereas its average is $16.3 million.
  • Within the past 5 years, the most significant YoY rise in Opko Health's Asset Writedowns and Impairment was 389894.74% (2015), while the steepest drop was 278867.31% (2015).
  • Opko Health's Asset Writedowns and Impairment (Quarter) stood at -$8.3 million in 2015, then soared by 362.13% to $21.8 million in 2018, then soared by 321.27% to $91.7 million in 2019.
  • Its Asset Writedowns and Impairment was $91.7 million in Q4 2019, compared to $655000.0 in Q1 2019 and $21.8 million in Q4 2018.